Vector Laboratories’ blog provides a wealth of information on immunohistochemistry (IHC), immunofluorescence (IF), and related life science research topics.
Join us at booth #603 to explore cancer detection, targeting, and biomarker research solutions powered by 50 years of expertise. At the AACR Annual Meeting 2026 in San Diego, Vector Laboratories is showcasing how its... Read more
Probing protein glycosylation uncovers new diagnostic and therapeutic avenues for breast cancer, one of the most common forms of cancer.
As colorectal cancer research continues to shift toward precision approaches, the ability to accurately detect and characterize key biomarkers is more important than ever.
Alzheimer’s Disease is complex disease on the rise worldwide. Glycosylation is critical to every facet of disease mechanisms and treatments.
Join us at booth #21 to explore solutions across spatial analysis, single cell proteomics, and biomarker discovery. This year, Vector Labs is highlighting new approaches to protein glycosylation and spatial biology, alongside our broader portfolio... Read more
Vector has been highly commended for the 2026 CiteAb Innovation Award, recognizing the impact of the Glysite Explorer in advancing glycosylation research.
Glycosylation is an understudied but critical component of colon carcinoma. The right tools aid in cancer research, diagnosis, and treatment.
Protein glycosylation is ubiquitous yet overlooked. Learn how Vector's suite of tools bring protein glycosylation insights to researchers across fields.
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
In the first of our three part series on Bioconjugation, we’ll be exploring what’s involved, how it enables life science research, the challenges associated with it, and the excitement in future work.
